Better Health for All

Dominari Holdings Inc. is primarily described as a financial services company, focusing on wealth management, investment banking, and asset management.

While some articles mention a 'Legacy AIkido' segment or the company's former name, AIkido Pharma Inc., with a focus on early-stage anti-cancer therapeutics, no specific data is provided regarding the health impact, revenue share, safety record, accessibility, or any other health-related metric for these activities. The provided articles explicitly state that data relevant to 'Better Health for All' metrics is unavailable or not applicable, precluding any scoring for these KPIs.

Fair Money & Economic Opportunity

Dominari Holdings Inc. operates as an investment vehicle, with subsidiaries focused on capital raising and investment opportunities.

The company's Master SPV LLC structure aims to democratize access to private market opportunities for various investors. Dominari Securities LLC seeks to create wealth for stakeholders by identifying early-stage opportunities expected to generate high returns, and the company declared three separate dividends in 2025, totaling approximately $22.2 million paid directly to shareholders. Dominari's app targets emerging markets, promising transparent, low-cost services without hidden fees, and aims to guide users in understanding investments and building savings. The app emphasizes a super simple registration process, quick KYC verification, and an easy-to-use interface, with products requiring a middle school level reading (grade 8-9). However, there is no specific data on the percentage of users showing credit-score rise, savings growth, homeownership, or business creation. The company's profit retention policies are standard, with no specific community finance reinvestment percentages provided. While the app aims to guide users, there are no quantifiable metrics on the reach or impact of financial literacy programs. The company does not provide debt products to consumers, nor does it operate financial service access points, making several KPIs not applicable.

Fair Pay & Worker Respect

As of February 10, 2025, none of Dominari Holdings Inc.'s employees or its subsidiaries' employees are members of a union, and neither the company nor its subsidiaries are party to a collective bargaining agreement.

As of December 31, 2024, Dominari had 29 full-time employees and offers health insurance to its employees, covering 80-85% of its workforce.

Honest & Fair Business

No specific, quantitative data points were found in the provided articles for any of the 'Honest & Fair Business' KPIs. Information regarding regulatory fines, transparency index scores, whistleblower policies, financial restatements, audit coverage, ESG controversy index scores, complaint resolution times, board conflict-free percentages, anti-corruption policies, or third-party verification of ethical claims was not available.

Several articles were inaccessible due to throttling, and the accessible articles explicitly stated a lack of data for these metrics.

Kind to Animals

Dominari Holdings Inc. undertakes pre-clinical studies on animals to examine the safety profile of its medications.

The company was formerly a biotech firm. No specific data regarding the volume of animals used, animal testing policies, use of alternative testing methods, or any certifications related to animal welfare is available in the provided articles.

No War, No Weapons

Dominari Holdings Inc. holds private shares of Anduril Industries, which is identified as a defense technology company.

This indicates an indirect tie to the defense sector, which is associated with weapons. Therefore, the company cannot claim zero exposure to weapons, aligning with a score of -80 for having indirect ties via subcontractors.

Zero Waste & Sustainable Products

Dominari Holdings Inc. (DOMH.US) has not reported any specific metrics or initiatives related to zero waste or sustainable products.

The provided articles focus on the company's financial performance, investment activities, and corporate governance, with explicit statements indicating an absence of data on waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back programs, circular design, waste reduction initiatives, hazardous waste management, product durability, repairability, waste audit frequency, zero-waste certification, waste disposal violations, material efficiency, packaging-to-product ratio, waste reduction targets, supplier waste requirements, or customer waste education.